ArticleThe Cochrane database of systematic reviews2025

Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists.

Guillaume Grenet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.